368 related articles for article (PubMed ID: 22781890)
1. [The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy].
Liu GQ; Ding HF; Lu XJ; Xu M; Xing J; Zhao X; Han F; Shang YH
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):188-91. PubMed ID: 22781890
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
[TBL] [Abstract][Full Text] [Related]
3. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of autologous platelet transfusion in cardiac surgery: comparison of cryopreservation, blood collection on the day before surgery, and blood collection during surgery.
Yokomuro M; Ebine K; Shiroma K; Tamura S; Kumabe S; Ohtuki M; Suzuki H; Uchida S
Cryobiology; 1999 May; 38(3):236-42. PubMed ID: 10328913
[TBL] [Abstract][Full Text] [Related]
5. Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot study.
Pedrazzoli P; Noris P; Perotti C; Schiavo R; Ponchio L; Belletti S; Da Prada GA; Balduini CL; Salvaneschi L; Robustelli Della Cuna G; Siena S
Br J Haematol; 2000 Mar; 108(3):653-9. PubMed ID: 10759725
[TBL] [Abstract][Full Text] [Related]
6. Autologous platelet collection and storage to support thrombocytopenia in patients undergoing high-dose chemotherapy and circulating progenitor cell transplantation for high-risk breast cancer.
Torretta L; Perotti C; Pedrazzoli P; Dornini G; Viarengo G; Livraghi A; Noris P; Da Prada GA; Balduini CL; della Cuna GR; Salvaneschi L
Vox Sang; 1998; 75(3):224-9. PubMed ID: 9852411
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of cryopreserved autologous platelet concentrates in HLA-alloimmunized patients with hematologic malignancies.
Gerber B; Alberio L; Rochat S; Stenner F; Manz MG; Buser A; Schanz U; Stussi G
Transfusion; 2016 Oct; 56(10):2426-2437. PubMed ID: 27339466
[TBL] [Abstract][Full Text] [Related]
8. Safety and clinical efficacy of platelet components prepared with pathogen inactivation in routine use for thrombocytopenic patients.
Schlenke P; Hagenah W; Irsch J; Sundin D; Corash L; Lin L; Kirchner H; Wagner T
Ann Hematol; 2011 Dec; 90(12):1457-65. PubMed ID: 21503644
[TBL] [Abstract][Full Text] [Related]
9. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
[TBL] [Abstract][Full Text] [Related]
10. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
[TBL] [Abstract][Full Text] [Related]
12. Review of in vivo studies of dimethyl sulfoxide cryopreserved platelets.
Slichter SJ; Jones M; Ransom J; Gettinger I; Jones MK; Christoffel T; Pellham E; Bailey SL; Corson J; Bolgiano D
Transfus Med Rev; 2014 Oct; 28(4):212-25. PubMed ID: 25439164
[TBL] [Abstract][Full Text] [Related]
13. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
Diedrich B; Ringdén O; Watz E; Shanwell A
Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
[TBL] [Abstract][Full Text] [Related]
14. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions.
Anderson NA; Gray S; Copplestone JA; Chan DC; Hamon M; Prentice AG; Johnson SA; Phillips M; van Waeg G; Oakhill A; Abeyasekera S; Pamphilon DH
Transfus Med; 1997 Mar; 7(1):33-9. PubMed ID: 9089983
[TBL] [Abstract][Full Text] [Related]
15. Cryopreserved autologous platelet transfusions in alloimmunized patients with acute leukemia.
Wiesneth M; Koerner K; Funke I; Seifried E; Cardoso M; Heimpel H; Kubanek B
Beitr Infusionsther; 1992; 30():297-300. PubMed ID: 1284720
[TBL] [Abstract][Full Text] [Related]
16. An audit of platelet transfusion within the Wellington Cancer Centre.
Buhrkuhl DC; Karlsson MK; Carter JM
Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
[TBL] [Abstract][Full Text] [Related]
17. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
[TBL] [Abstract][Full Text] [Related]
18. [The efficacy and mechanism of rhIL-11 in the management of chemotherapy-induced thrombocytopenia in acute leukemia].
Cui XL; Wang L; Gao J; Qin P; Shi Y; Peng J; Hou M
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):345-7. PubMed ID: 16185478
[TBL] [Abstract][Full Text] [Related]
19. Pathogen-inactivation of platelet components with the INTERCEPT Blood System ™: a cohort study.
Infanti L; Stebler C; Job S; Ruesch M; Gratwohl A; Irsch J; Lin L; Buser A
Transfus Apher Sci; 2011 Oct; 45(2):175-81. PubMed ID: 21840762
[TBL] [Abstract][Full Text] [Related]
20. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
